(Q64139322)
Statements
Randomized, Double-blind, Placebo-controlled Trial to Investigate Safety, Tolerability, and Pharmacokinetics of Multiple Rising Oral Doses of BI 685509 Over 28 Days in Patients With Mild and Moderate Hepatic Impairment and of Single Oral BI 685509 Dose Compared to Healthy Volunteers (English)
0 references
6 March 2019
0 references
24 April 2020
0 references
64
0 references
18 year
0 references